Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol BMP4 contributors: shn/mct - updated : 26-05-2017
HGNC name bone morphogenetic protein 4
HGNC id 1071
ASSOCIATED DISORDERS
corresponding disease(s) MCOPS6 , DEL14Q22
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --over  
in patients with fibrodysplasia ossificans progressive (FOP)
constitutional     --over  
in a syndrome of axial skeletal malformations and heterotopic ossification of the neck and back (ASMHO), analog to the short ear mouse
constitutional germinal mutation      
in ASD, VSD
constitutional     --over  
in synovial chondromatosis
constitutional     --over  
in RPE cells in both the early and late form of dry Age-related Macular Degeneration
constitutional       loss of function
of SIX2 and BMP4, could affect kidney development at multiple stages, leading to the congenital anomalies observed in patients with renal hypodysplasia
tumoral germinal mutation      
in colorectal cancer (CRC)
constitutional   deletion    
detected in a patient affected with SHORT syndrome
constitutional     --over  
may be associated with Sertoli cell-only syndrome and maturation arrest in spermatogonia or spermatocytes
constitutional     --over  
aberrant BMP4-mediated signaling in cranial neural crest (CNC) cells leads to mis-patterned facial skeleton and congenital bony syngnathia
Susceptibility
  • to hypospadias
  • to microform and subepithelial orbicularis oris muscle (OOM) defects
  • to congenital anomalies of the kidney and urinary tract
  • Variant & Polymorphism SNP , other
  • polymorphism increasing the risk of hypospadias
  • SNP modulating hemochromatosis penetrance
  • amino acid variations in BMP4 are associated with microform and subepithelial OOM defects
  • polymorphisms of the BMP4 gene have a higher risk to develop CAKUT, especially the malformations related to nephrogenesis
  • Candidate gene
    Marker
    Therapy target
  • non-cytotoxic therapeutic effector which may be used to prevent growth and recurrence of glioblastomas
  • SystemTypeDisorderPubmed
    osteoarticularbone 
    BMP antagonists such as noggin might be useful therapeutic tools for preventing chondrogenic metaplasia occurred in synovial chondromatosis
    cancerlung 
    responsive molecular target for cancer chemotherapy in lung carcinoma
    neurosensorial  
    may represent a novel therapeutic target to inhibit the progressive effects of oxidative stress and senescence in dry age-related macular degeneration
    diabetetype 2 
    preferential inhibition of the BMP4 signaling pathway may provide a novel therapeutic approach to diabetic nephropathy without undesirable adverse effects
    cancer  
    BMP4 may become an antitumor agent and open a new field of antiangiogenic therapy
    ANIMAL & CELL MODELS
  • early lethality of Bmp4 null mouse embryos
  • development of progressive postnatal heterotopic endochondral ossification has been observed in mice overexpressing BMP4